Related references
Note: Only part of the references are listed.Association of Long-term Administration of the Survivin mRNA-Targeted Antisense Oligonucleotide LY2181308 With Reversible Kidney Injury in a Patient With Metastatic Melanoma
William G. Herrington et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model
Takahito Nakahara et al.
ANTI-CANCER DRUGS (2011)
Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors
M. Tanioka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Antitumor Activity of YM155, a Selective Small-Molecule Survivin Suppressant, Alone and in Combination with Docetaxel in Human Malignant Melanoma Models
Kentaro Yamanaka et al.
CLINICAL CANCER RESEARCH (2011)
Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer
Pablo E. Vivas-Mejia et al.
CLINICAL CANCER RESEARCH (2011)
Antisense Inhibition of Survivin Expression as a Cancer Therapeutic
Rosa A. Carrasco et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
T. Iwasa et al.
BRITISH JOURNAL OF CANCER (2010)
Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma
Markus D. Siegelin et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Caspase 2-mediated tumor suppression involves survivin gene silencing
M. Guha et al.
ONCOGENE (2010)
Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability
Cynthia A. Pise-Masison et al.
BLOOD (2009)
Endogenous Tumor Suppression Mediated by PTEN Involves Survivin Gene Silencing
Minakshi Guha et al.
CANCER RESEARCH (2009)
Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
Jing Lu et al.
CLINICAL CANCER RESEARCH (2009)
Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Taroh Satoh et al.
CLINICAL CANCER RESEARCH (2009)
Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non-Small-Cell Lung Cancer
Giuseppe Giaccone et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions
Michel R. Nasr et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2008)
Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin - Mediated increases in survivin expression
Seung Hyun Oh et al.
CLINICAL CANCER RESEARCH (2008)
SPC3042:: a proapoptotic survivin inhibitor
Jens Bo Hansen et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
Rui-Hong Wang et al.
MOLECULAR CELL (2008)
New wirings in the survivin networks
D. C. Altieri
ONCOGENE (2008)
Chemically synthesized human survivin does not inhibit caspase-3
Changqing Li et al.
PROTEIN SCIENCE (2008)
Phase I/II clinical safety studies of terameprocol vaginal ointment
Niharika Khanna et al.
GYNECOLOGIC ONCOLOGY (2007)
Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together
A. Arockia Jeyaprakash et al.
CELL (2007)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection
Takehiko Dohi et al.
MOLECULAR CELL (2007)
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Andrei Goga et al.
NATURE MEDICINE (2007)
Phosphorylation by aurora-B negatively regulates survivin function during mitosis
Sally P. Wheatley et al.
CELL CYCLE (2007)
Regulation of survivin expression by IGF-1/mTOR signaling
V. Vaira et al.
ONCOGENE (2007)
Mechanisms of mitotic cell death induced by chemotherapy-mediated G(2) checkpoint abrogation
Celia Vogel et al.
CANCER RESEARCH (2007)
Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure
Femke Zwerts et al.
BLOOD (2007)
A Bir1-Sli15 complex connects centromeres to microtubules and is required to sense kinetochore tension
Sharsti Sandall et al.
CELL (2006)
Activated checkpoint kinase 2 provides a survival signal for tumor cells
Jagadish C. Ghosh et al.
CANCER RESEARCH (2006)
The case for Survivin as mitotic regulator
Susanne M. A. Lens et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
The case for survivin as a regulator of microtubule dynamics and cell-death decisions
Dario C. Altieri
CURRENT OPINION IN CELL BIOLOGY (2006)
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Brendan P. Eckelman et al.
EMBO REPORTS (2006)
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer
Mads Hald Andersen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein
Byoung Heon Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins
Hao G. Nguyen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Survivin, a cancer target with an emerging role in normal adult tissues
Seiji Fukuda et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Survivin modulates microtubule dynamics and nucleation throughout the cell cycle
J Rosa et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Chromosome alignment and segregation regulated by ubiquitination of survivin
QP Vong et al.
SCIENCE (2005)
Adenoviral infection of survivin antisense sensitizes prostate cancer cells to etoposide in vivo
N Hayashi et al.
PROSTATE (2005)
Rational design of shepherdin, a novel anticancer agent
J Plescia et al.
CANCER CELL (2005)
Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma
ET Shinohara et al.
CANCER (2005)
Survivin mediates resistance to antiandrogen therapy in prostate cancer
M Zhang et al.
ONCOGENE (2005)
Survivin 2α:: a novel survivin splice variant expressed in human malignancies
Hugo Caldas et al.
MOLECULAR CANCER (2005)
Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53
M Kappler et al.
CANCER GENE THERAPY (2004)
Identification of a novel splice variant of the human anti-apoptosis gene survivin
A Badran et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Aberrant regulation of survivin by the RB/E2F family of proteins
YY Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression
CC Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells
L You et al.
ONCOGENE (2004)
The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly
SC Sampath et al.
CELL (2004)
Molecular mechanisms of caspase regulation during apoptosis
SJ Riedl et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Cell division and cell survival in the absence of survivin
D Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regulation of survivin function by Hsp90
P Fortugno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Survivin, versatile modulation of cell division and apoptosis in cancer
DC Altieri
ONCOGENE (2003)
Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras
KW Sommer et al.
ONCOGENE (2003)
HBXIP functions as a cofactor of survivin in apoptosis suppression
H Marusawa et al.
EMBO JOURNAL (2003)
Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis
C Cohen et al.
MODERN PATHOLOGY (2003)
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
Y Aoki et al.
BLOOD (2003)
Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma
P Grabowski et al.
BRITISH JOURNAL OF CANCER (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and in a complex inase activity is phosphorylation
MA Bolton et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
J Tran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma
AI Sarela et al.
BRITISH JOURNAL OF CANCER (2002)
Quantitatively determined survivin expression levels are of prognostic value in human gliomas
A Chakravarti et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Transcriptional repression of the anti-apoptotic survivin gene by wild type p53
WH Hoffman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors:: implication of survivin expression in normal hematopoiesis
S Fukuda et al.
BLOOD (2001)
INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis
SP Wheatley et al.
CURRENT BIOLOGY (2001)
Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa
R Gianani et al.
HUMAN PATHOLOGY (2001)
Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype
AG Uren et al.
CURRENT BIOLOGY (2000)
Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual α-helical extensions
L Chantalat et al.
MOLECULAR CELL (2000)
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
A Islam et al.
ONCOGENE (2000)
Control of apoptosis during angiogenesis by survivin expression in endothelial cells
DS O'Connor et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
